26 related articles for article (PubMed ID: 35644470)
21. HIF-1α and Nrf2 regulates hypoxia induced overexpression of DDAH1 through promoter activation in prostate cancer.
Parveen SMA; Natani S; Sruthi K K ; Khilar P; Ummanni R
Int J Biochem Cell Biol; 2022 Jun; 147():106232. PubMed ID: 35644470
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
23. Targeting HIF-1 for prostate cancer: a synthesis of preclinical evidence.
Zohar Y; Mabjeesh NJ
Expert Opin Ther Targets; 2023; 27(8):715-731. PubMed ID: 37596912
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in DDAH1 inhibitor design and discovery: insights from structure-activity relationships and X-ray crystal structures.
Doman AJ; Perkins MV; Tommasi S; Mangoni AA; Nair PC
RSC Adv; 2024 Mar; 14(14):9619-9630. PubMed ID: 38525060
[TBL] [Abstract][Full Text] [Related]
25.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
